Palofer 0.25mg / 5ml injection

Ferron Par Pharmaceuticals

Ingredients in every 5 ml

Palonosetron HCl 0.25 mg

Each package contains

1 vial of 5 ml

Other details

Dosage form:Injection
Flavour None

W.H.O. classification

ATC Level 1 A - Alimentary tract and metabolism
ATC Level 2 A04 - Antiemetics and Antinauseants
ATC Level 3 A04A - Antiemetics and Antinauseants

Warnings

Pregnancy

NOT SAFEThis item is not safe for use during pregnancy.

Lactation

NOT SAFEThis item is not safe for use during lactation.

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

CAUTIONThis item may not be safe for use while operating heavy machinery. Use with caution and after consultation with your doctor.

Available in

Indonesia

Dosage information

18 YEARS OLD AND ABOVE
250 micrograms palonosetron as single intravenous bolus.
Applied approximately 30 minutes before the start of chemotherapy. Palonosetron should be injected over 30 seconds.

Repeated dosing of palonosetron within a seven day interval is not recommended. The efficacy of palonosetron in the prevention of nausea and vomiting induced by highly emetogenic chemotherapy may be enhanced by the addition of corticosteroid administered prior to chemotherapy.

OTHER DETAILS
ELDERLY
No dose adjustment is necessary for the elderly.

HEPATIC IMPAIRMENT
No dose adjustment is necessary for patients with impaired hepatic function.

RENAL IMPAIRMENT
No dose adjustment is necessary for patients with impaired renal function. No data are available for patients with end stage renal disease undergoing hemodialysis.

Indication

– The prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy.
– The prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.